ABO blood group and von Willebrand factor: biological implications

被引：45
作者：
Franchini, Massimo [1 ]
Crestani, Silvia [1 ]
Frattini, Francesco [1 ]
Sissa, Cinzia [1 ]
Bonfanti, Carlo [1 ]
机构：
[1] Azienda Osped Carlo Poma, Dipartimento Med Trasfus & Ematol, Mantua, Italy
来源：
CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2014年 / 52卷 / 09期
关键词：
ABO; ADAMTS13; desmopressin; LRP1; von Willebrand disease; von Willebrand factor; N-LINKED GLYCOSYLATION; GENETIC RISK-FACTOR; FACTOR-VIII; ADAMTS13; PROTEOLYSIS; VASCULAR-DISEASE; HALF-LIFE; IN-VIVO; CLEARANCE; PHENOTYPE; COHORT;
D O I：
10.1515/cclm-2014-0564
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
ABO blood group antigens are complex carbohydrate molecules expressed on the surface of red blood cells and a variety of human cells and tissues. It is well known that ABO blood type exerts a profound influence on hemostasis, being a major determinant of von Willebrand factor (VWF), and consequently factor VIII, plasma levels. In this review, we will focus on the molecular mechanisms underlying the interaction between ABO blood group and VWF in normal and pathological conditions.
引用
收藏
页码：1273 / 1276
页数：4
相关论文
共 37 条
  • [21] Beyond immunohaematology: the role of the ABO blood group in human diseases
    Liumbruno, Giancarlo Maria
    Franchini, Massimo
    [J]. BLOOD TRANSFUSION, 2013, 11 (04) : 491 - 499
  • [22] Altered glycosylation of platelet-derived von Willebrand factor confers resistance to ADAMTS13 proteolysis
    McGrath, Rachel T.
    van den Biggelaar, Maartje
    Byrne, Barry
    O'Sullivan, Jamie M.
    Rawley, Orla
    O'Kennedy, Richard
    Voorberg, Jan
    Preston, Roger J. S.
    O'Donnell, James S.
    [J]. BLOOD, 2013, 122 (25) : 4107 - 4110
  • [23] Expression of terminal α2-6-linked sialic acid on von Willebrand factor specifically enhances proteolysis by ADAMTS13
    McGrath, Rachel T.
    McKinnon, Thomas A. J.
    Byrne, Barry
    O'Kennedy, Richard
    Terraube, Virginie
    McRae, Emily
    Preston, Roger J. S.
    Laffan, Mike A.
    O'Donnell, James S.
    [J]. BLOOD, 2010, 115 (13) : 2666 - 2673
  • [24] Platelet von Willebrand factor - structure, function and biological importance
    McGrath, Rachel T.
    McRae, Emily
    Smith, Owen P.
    O'Donnell, James S.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 148 (06) : 834 - 843
  • [25] N-linked glycosylation of VWF modulates its interaction with ADAMTS13
    McKinnon, Thomas A. J.
    Chion, Alain C. K.
    Millington, Alexander J.
    Lane, David A.
    Laffan, Mike A.
    [J]. BLOOD, 2008, 111 (06) : 3042 - 3049
  • [26] Specific N-linked glycosylation sites modulate synthesis and secretion of von Willebrand factor
    McKinnon, Thomas A. J.
    Goode, Elizabeth C.
    Birdsey, Graeme M.
    Nowak, Agata A.
    Chan, Alain C. K.
    Lane, David A.
    Laffan, Michael A.
    [J]. BLOOD, 2010, 116 (04) : 640 - 648
  • [27] Survival of von Willebrand factor released following DDAVP in a type I von Willebrand disease cohort: Influence of glycosylation, proteolysis and gene mutations
    Millar, Carolyn M.
    Riddell, Anne F.
    Brown, Simon A.
    Starke, Richard
    Mackie, Ian
    Bowen, Derrick J.
    Jenkins, P. Vincent
    van Mourik, Jan A.
    [J]. THROMBOSIS AND HAEMOSTASIS, 2008, 99 (05) : 916 - 924
  • [28] Influence of ABO blood groups on primary hemostasis
    Moeller, A
    Weippert-Kretschmer, M
    Prinz, H
    Kretschmer, V
    [J]. TRANSFUSION, 2001, 41 (01) : 56 - 60
  • [29] The relationship between ABO histo-blood group, factor VIII and von Willebrand factor
    O'Donnell, J
    Laffan, MA
    [J]. TRANSFUSION MEDICINE, 2001, 11 (04) : 343 - 351
  • [30] Bombay phenotype is associated with reduced plasma-VWF levels and an increased susceptibility to ADAMTS13 proteolysis
    O'Donnell, JS
    McKinnon, TAJ
    Crawley, JTB
    Lane, DA
    Laffan, MA
    [J]. BLOOD, 2005, 106 (06) : 1988 - 1991
1234